The ROE (Return on Equity) of Xenon Pharmaceuticals Inc (XENE) is -31.04%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2024-12-31 | -31.04% |
| 2023-12-31 | -19.66% |
| 2022-12-31 | -17.38% |
| 2021-12-31 | -14.34% |
| 2020-12-31 | -16.83% |
| 2019-12-31 | -45.22% |
| 2018-12-31 | -33.40% |
| 2017-12-31 | -85.52% |
| 2016-12-31 | -35.99% |
| 2015-12-31 | -25.82% |